Literature DB >> 7421931

Enhanced helminthotoxic capacity of eosinophils from patients with eosinophilia.

J R David, M A Vadas, A E Butterworth, P A de Brito, E M Carvalho, R A David, J C Bina, Z A Andrade.   

Abstract

To determine whether eosinophils from patients with eosinophilia have an enhanced capacity to kill parasites, we compared purified eosinophils (mean purity, 89 per cent) from 30 patients with various degrees of eosinophilia and with or without infection with Schistosoma mansoni for the capacity to kill schistosomula, the larval stage of S. mansoni, in vitro. There was a significant correlation between peripheral eosinophil count and antibody-dependent, eosinophil-mediated death of parasites after 40 hours of culture (P < 0.0001). Antibody-dependent adherence of eosinophils, measured after two hours of incubation, also correlated with the capacity of the eosinophils to kill the parasites. The correlation between the killing capacity of eosinophils and their peripheral-blood count was observed in patients both with and without S. mansoni infection. We suggest that eosinophilia involves not only a quantitative change in eosinophil numbers but also a qualitative change in functional capacity that renders circulating eosinophils more effective in resisting parasitic infections.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7421931     DOI: 10.1056/NEJM198011133032004

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  26 in total

1.  Enhanced granulocyte cytotoxicity by mediators derived from anti-IgE-stimulated human leucocytes.

Authors:  R Moqbel; A J MacDonald; A B Kay
Journal:  Immunology       Date:  1986-09       Impact factor: 7.397

Review 2.  The IgE receptor of eosinophils.

Authors:  M Capron; L Prin
Journal:  Springer Semin Immunopathol       Date:  1990

Review 3.  Colony-stimulating factors in the pathogenesis and treatment of disease.

Authors:  D J Williamson; C G Begley
Journal:  Postgrad Med J       Date:  1987-12       Impact factor: 2.401

4.  Eosinophil activity in Schistosoma mansoni infections in vivo and in vitro in relation to plasma cytokine profile pre- and posttreatment with praziquantel.

Authors:  Claus M Reimert; Colin M Fitzsimmons; Sarah Joseph; Joseph K Mwatha; Frances M Jones; Gachuhi Kimani; Karl F Hoffmann; Mark Booth; Narcis B Kabatereine; David W Dunne; Birgitte J Vennervald
Journal:  Clin Vaccine Immunol       Date:  2006-05

5.  Schistosoma japonicum: in vitro killing of schistosomula by mouse neutrophils.

Authors:  Y Irie; S Maeda; K Yasuraoka
Journal:  Z Parasitenkd       Date:  1985

Review 6.  Eosinophils as effector cells in immunity and hypersensitivity disorders.

Authors:  A B Kay
Journal:  Clin Exp Immunol       Date:  1985-10       Impact factor: 4.330

7.  Reciprocal inhibition of binding between interleukin 3 and granulocyte-macrophage colony-stimulating factor to human eosinophils.

Authors:  A F Lopez; J M Eglinton; D Gillis; L S Park; S Clark; M A Vadas
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

8.  Heterogeneity of human eosinophils. II. Variability of respiratory burst activity related to cell density.

Authors:  L Prin; J Charon; M Capron; P Gosset; H Taelman; A B Tonnel; A Capron
Journal:  Clin Exp Immunol       Date:  1984-09       Impact factor: 4.330

9.  Arachidonic acid metabolism in normal and hypereosinophilic syndrome human eosinophils: generation of leukotrienes B4, C4, D4 and 15-lipoxygenase products.

Authors:  W R Henderson; J B Harley; A S Fauci
Journal:  Immunology       Date:  1984-04       Impact factor: 7.397

10.  Presence of factors chemotactic for granulocytes in hypereosinophilic syndrome sera: relation with alterations in eosinophil migration.

Authors:  P Gosset; L Prin; M Capron; C Auriault; A B Tonnel; A Capron
Journal:  Clin Exp Immunol       Date:  1986-09       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.